Both BMCs and EVs have been implicated in contributing to the pathogenesis of neurodegenerative diseases where the pathology is dictated in part by neuroimmune mechanisms, such as the presence of amyloid-β peptide (Aβ) [104,105,106] and Tau [95,107]. Here, MAPT is linked to neurodegenerative disease.